Rankings

Share buybacks, ranked

134 large listed companies across the United States, the Netherlands and Europe. Figures are from company cash-flow statements, latest period ending Aug 2026, converted to US dollars for comparison.

Showing 18 of 134 companies · Healthcare, sorted by buybacks (latest 12 months).

#	Company	Sector
1	Johnson & Johnson JNJNYSE	Healthcare	$8.07B TTM	1.3%	3.3%	$22.9B	Share count change −8.6%
2	Novartis AG NOVNSWEU	Healthcare	$6.76B TTM	2.5%	5.9%	$40.4B	Share count change −15.0%
3	Eli Lilly and Company LLYNYSE	Healthcare	$6.17B TTM	0.6%	1.1%	$10.1B	Share count change −6.3%
4	UnitedHealth Group Incorporated UNHNYSE	Healthcare	$5.54B FY2025	1.6%	4.0%	$34.5B	Share count change −5.1%
5	McKesson Corporation MCKNYSE	Healthcare	$4.75B FY2026	4.3%	4.7%	$18.1B	Share count change −21.4%
6	Merck & Company Inc MRKNYSE	Healthcare	$4.21B TTM	1.2%	3.5%	$8.19B	Share count change −2.5%
7	Cigna Corp CINYSE	Healthcare	$3.72B TTM	5.0%	7.2%	$28.3B	Share count change −19.9%
8	Thermo Fisher Scientific Inc TMONYSE	Healthcare	$3.00B FY2025	1.2%	1.5%	$15.0B	Share count change −6.8%
9	Danaher Corporation DHRNYSE	Healthcare	$2.90B TTM	1.9%	2.5%	$3.88B	Share count change −4.2%
10	Elevance Health Inc ELVNYSE	Healthcare	$2.71B TTM	3.0%	4.7%	$12.4B	Share count change −11.2%
11	Gilead Sciences Inc GILDNASDAQ	Healthcare	$1.44B TTM	0.8%	2.9%	$6.01B	Share count change −1.5%
12	Roche Holding AG ROGSWEU	Healthcare	$1.19B CHF 987M · FY2025	0.4%	3.7%	$28.3B	Share count change −7.0%
13	AbbVie Inc ABBVNYSE	Healthcare	$980M FY2025	0.2%	2.6%	$7.08B	Share count change −0.4%
14	Novo Nordisk A/S NOVO-BCOEU	Healthcare	$884M DKK 5.90B · TTM	0.5%	5.1%	$14.2B	Share count change −3.2%
15	Amgen Inc AMGNNASDAQ	Healthcare	$0 FY2025	0.0%	2.3%	$11.5B	Share count change −3.7%
16	Bristol-Myers Squibb Company BMYNYSE	Healthcare	$0 FY2025	0.0%	4.2%	$19.4B	Share count change −7.7%
17	Koninklijke Philips NV PHIAASNL	Healthcare	$0 €0 · FY2025	0.0%	1.5%	$3.25B	Share count change +8.3%
18	Pfizer Inc PFENYSE	Healthcare	— FY2025	—	6.1%	$2.00B	Share count change −1.2%

Buybacks is cash spent on repurchases in the latest four reported quarters when all four are available and non-negative, otherwise the latest fiscal year (labelled FY). A negative value means the company issued more shares than it bought.

Buyback yield divides that figure by today's market capitalisation. Shares 5-yr compares the latest reported share count with the count roughly five years earlier. Dataset generated October 10, 2026.